神经兴奋剂的使用与心脏骤停后昏迷患者生存改善相关,且不受脑电图特征影响
该回顾性队列纳入585例心脏骤停后昏迷且接受脑电图监测的患者,其中47例(8%)接受了神经兴奋剂治疗。神经兴奋剂使用独立预测出院生存改善(aOR 4.00,95%CI 1.68-9.52),但功能良好生存无差异。在脑电图呈不连续背景、无反应性或恶性图案的各亚组中,神经兴奋剂均与出院生存增加相关。作者认为,脑电图的不良图案不应单独影响神经兴奋剂使用的考虑,但研究受观察性设计和选择偏倚限制。
要点
- 在585例心脏骤停后昏迷患者中,8%使用神经兴奋剂,其与出院生存改善独立相关(aOR 4.00,95%CI 1.68-9.52)。
- 功能良好生存( functionally favorable survival)在神经兴奋剂组与未使用组间无差异。
- 无任何脑电图特征能预测神经兴奋剂治疗后的有利反应(觉醒)。
- 脑电图不连续背景亚组:神经兴奋剂组出院生存44% vs 未使用组7%(P=0.004)。
- 脑电图无反应性亚组:56% vs 6%(P<0.001);恶性图案亚组:63% vs 5%(P<0.001)。
适用人群与场景
- 心脏骤停后昏迷且接受脑电图监测的连续患者;神经兴奋剂组以给药前最后一天脑电图分类,未使用组以最后24小时记录分类。
诊断标准与关键阈值
- 脑电图分类基于连续性(连续/不连续)、反应性(有/无)和恶性图案(周期性放电、爆发抑制、肌阵挛性癫痫持续状态或癫痫发作;有/无)。
研究设计与关键结果
- 回顾性队列,585例,平均(SD)年龄57(17)岁,女性227例(39%),47例(8%)接受神经兴奋剂。
- 神经兴奋剂使用独立预测出院生存改善(aOR 4.00,95%CI 1.68-9.52),功能良好生存无差异。
- 无脑电图特征预测神经兴奋剂后的有利反应(觉醒)。
- 不连续背景亚组:神经兴奋剂组出院生存44% vs 未使用组7%(P=0.004)。
- 无反应性背景亚组:56% vs 6%(P<0.001)。
- 恶性图案亚组:63% vs 5%(P<0.001)。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:观察性性质与潜在选择偏倚(原文自述)。
对床旁实践的改变
- 作者认为,脑电图的不良图案不应单独影响神经兴奋剂使用的考虑。
- 神经兴奋剂与出院生存改善相关,但功能良好生存无差异,且无脑电图特征预测有利反应。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
AIM: Identify EEG patterns that predict or preclude favorable response in comatose post-arrest patients receiving neurostimulants.
METHODS: We examined a retrospective cohort of consecutive electroencephalography (EEG)-monitored comatose post-arrest patients. We classified the last day of EEG recording before neurostimulant administration based on continuity (continuous/discontinuous), reactivity (yes/no) and malignant patterns (periodic discharges, suppression burst, myoclonic status epilepticus or seizures; yes/no). In subjects who did not receive neurostimulants, we examined the last 24h of available recording. For our primary analysis, we used logistic regression to identify EEG predictors of favorable response to treatment (awakening).
RESULTS: In 585 subjects, mean (SD) age was 57 (17) years and 227 (39%) were female. Forty-seven patients (8%) received a neurostimulant. Neurostimulant administration independently predicted improved survival to hospital discharge in the overall cohort (adjusted odds ratio (aOR) 4.00, 95% CI 1.68-9.52) although functionally favorable survival did not differ. No EEG characteristic predicted favorable response to neurostimulants. In each subgroup of unfavorable EEG characteristics, neurostimulants were associated with increased survival to hospital discharge (discontinuous background: 44% vs 7%, P=0.004; non-reactive background: 56% vs 6%, P<0.001; malignant patterns: 63% vs 5%, P<0.001).
CONCLUSION: EEG patterns described as ominous after cardiac arrest did not preclude survival or awakening after neurostimulant administration. These data are limited by their observational nature and potential for selection bias, but suggest that EEG patterns alone should not affect consideration of neurostimulant use.
参考来源
- Steinberg A, Rittenberger JC, Baldwin M, et al. Neurostimulant use is associated with improved survival in comatose patients after cardiac arrest regardless of electroencephalographic substrate. Resuscitation. 2017. PMID: 29221942. doi:10.1016/j.resuscitation.2017.12.002
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。